CERO
CERO THERAPEUTICS HOLDINGS, INC.
Biological Products, (No Diagnostic Substances)OTC<br>Emerging growth company
Total Trades
2
Buys
0
Sells
2
Largest Trade
$100K–$500K
Insiders
2
Institutional Funds
3
Inst. Value
$100K–$500K
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| SLOAN STUART M | 10% Owner | SELL | $50K–$100K | 532K | $0.10 | Nov 20, 2024 |
| YK Bioventures Opportunities GP I, LLC | 10% Owner | SELL | $100K–$500K | 3.3M | $0.10 | Nov 15, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Sep 30, 2025 · 3 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ARCH Venture Management, LLC | 22K | $100K–$500K | SH |
| FNY Investment Advisers, LLC | 1K | $1K–$15K | SH |
| BANK OF AMERICA CORP /DE/ | 3 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Aug 15, 2025
5.0%
63K shares
SC 13G · May 15, 2025
10.0%
585K shares